Lisata TherapeuticsLSTA
13F holders, Q2 2026 (June 30)31holders −3
3new positions
5sold out
1famous investor
$3.40avg. 13F price*
At the end of Q2 2026, 31 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings, down 3 from Q1 2026. 3 opened new positions and 5 sold out. The largest holders were Vanguard Capital Management LLC ($948K), Yakira Capital Management, Inc. ($471K) and CSS LLC ($375K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lisata Therapeutics Inc.
- CUSIP
- 128058302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $535K |
| Exits | 5 | $966K |
All 13F filers, Q1 2026 → Q2 2026: 257,726 shares bought and 213,772 shares sold, net +43,954 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Vanguard Capital Management LLC | 0.00% | Add +2.6% | 278,837 | $948K |
| Yakira Capital Management, Inc. | 0.14% | New | 138,561 | $471K |
| CSS LLC | 0.05% | Add +78.4% | 110,422 | $375K |
| Deltec Asset Management LLC | 0.04% | Reduce -7.6% | 83,197 | $283K |
| Rangeley Capital, LLC | 0.27% | Add +8.0% | 81,000 | $275K |
| Geode Capital Management, LLC | 0.00% | Add +2.5% | 72,632 | $247K |
| Virtu Financial LLC | 0.01% | Add +39.3% | 58,782 | $200K |
| BlackRock, Inc. | 0.00% | No change | 54,857 | $187K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +40.2% | 48,964 | $166K |
| GTS Securities LLC | 0.00% | Reduce -3.8% | 30,200 | $103K |
| State Street Corp. | 0.00% | No change | 25,348 | $86K |
| Jane Street Group, LLC | 0.00% | New | 18,741 | $64K |
| Citadel Advisors | 0.00% | Reduce -31.4% | 15,541 | $53K |
| Northern Trust Corp. | 0.00% | Add +51.3% | 15,534 | $53K |
| JBF Capital, Inc. | 0.01% | Add +8.4% | 14,347 | $49K |
| Cerity Partners LLC | 0.00% | No change | 12,183 | $41K |
| Bank of America Corp. | 0.00% | No change | 10,353 | $35K |
| HighTower Advisors, LLC | 0.00% | No change | 10,042 | $34K |
| International Assets Investment Management, LLC | 0.00% | No change | 5,000 | $17K |
| Founders Capital Management | 0.00% | No change | 1,667 | $6K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 1,033 | $4K |
| Connective Capital Management, LLC | 0.00% | No change | 1,016 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -7.5% | 726 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $680 |
| Caitong International Asset Management Co., Ltd | 0.00% | Add +309.1% | 90 | $306 |
| Morgan Stanley | 0.00% | No change | 75 | $255 |
| Barclays PLC | 0.00% | New | 70 | $238 |
| SBI Securities Co., Ltd. | 0.00% | No change | 7 | $24 |
| Cheviot Value Management, LLC | 0.00% | No change | 3 | $10 |
| Fortitude Family Office, LLC | 0.00% | No change | 1 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -99.1% | 52 | $0 |
"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.